JP2023515747A5 - - Google Patents
Info
- Publication number
- JP2023515747A5 JP2023515747A5 JP2022539336A JP2022539336A JP2023515747A5 JP 2023515747 A5 JP2023515747 A5 JP 2023515747A5 JP 2022539336 A JP2022539336 A JP 2022539336A JP 2022539336 A JP2022539336 A JP 2022539336A JP 2023515747 A5 JP2023515747 A5 JP 2023515747A5
- Authority
- JP
- Japan
- Prior art keywords
- cell
- cells
- domain
- immune
- polypeptide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962954448P | 2019-12-28 | 2019-12-28 | |
| US62/954,448 | 2019-12-28 | ||
| PCT/IB2020/001079 WO2021130535A2 (en) | 2019-12-28 | 2020-12-28 | Cell expressing immune modulatory molecules and system for expressing immune modulatory molecules |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023515747A JP2023515747A (ja) | 2023-04-14 |
| JP2023515747A5 true JP2023515747A5 (enExample) | 2024-01-11 |
Family
ID=75377831
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022539336A Pending JP2023515747A (ja) | 2019-12-28 | 2020-12-28 | 免疫調節分子を発現する細胞および免疫調節分子を発現するための系 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20230058519A1 (enExample) |
| EP (1) | EP4081545A2 (enExample) |
| JP (1) | JP2023515747A (enExample) |
| CN (1) | CN115103857B (enExample) |
| WO (1) | WO2021130535A2 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN116410332B (zh) * | 2021-12-29 | 2025-04-15 | 上海细胞治疗集团股份有限公司 | 抗间皮素纳米抗体嵌合抗原受体及其应用 |
| CN118206620A (zh) * | 2022-12-09 | 2024-06-18 | 上海细胞治疗集团股份有限公司 | 一种多肽标签及其应用 |
| CN119269786A (zh) * | 2023-06-29 | 2025-01-07 | 上海细胞治疗集团股份有限公司 | 一种评估car产生细胞免疫应答的方法 |
| WO2025209437A1 (zh) * | 2024-04-02 | 2025-10-09 | 原启生物科技(上海)有限责任公司 | 经修饰的免疫细胞及其用途 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2007042289A2 (en) * | 2005-10-11 | 2007-04-19 | Ablynx N.V. | Nanobodies™ and polypeptides against egfr and igf-ir |
| US9670275B2 (en) * | 2012-01-23 | 2017-06-06 | Ablynx N.V. | Sequences directed against hepatocyte growth factor (HGF) and polypeptides comprising the same for the treatment of cancers and/or tumors |
| CN113684185A (zh) * | 2013-02-26 | 2021-11-23 | 纪念斯隆-凯特琳癌症中心 | 用于免疫疗法的组合物和方法 |
| WO2015197582A1 (en) * | 2014-06-27 | 2015-12-30 | Innate Pharma | Monomeric multispecific antigen binding proteins |
| EP4643874A3 (en) * | 2015-12-22 | 2026-02-11 | Novartis AG | Mesothelin chimeric antigen receptor (car) and antibody against pd-l1 inhibitor for combined use in anticancer therapy |
| TWI755547B (zh) * | 2016-01-21 | 2022-02-21 | 美商輝瑞股份有限公司 | 靶向表皮生長因子受體變異體iii之嵌合型抗原受體 |
| US20190048085A1 (en) * | 2016-02-25 | 2019-02-14 | Cell Medica Switzerland Ag | Modified cells for immunotherapy |
| EP3568416A4 (en) * | 2017-01-13 | 2020-07-08 | Celdara Medical, LLC | TIM-1 TARGETED CHIMERIC ANTIGENIC RECEPTORS |
| JP7611705B2 (ja) * | 2018-06-22 | 2025-01-10 | ザ ジェネラル ホスピタル コーポレイション | Ｃｄ３７及びｃｄ１９を標的とするキメラ抗原受容体 |
| EP3930754A4 (en) | 2019-02-27 | 2023-08-16 | Zhejiang Nanomab Technology Center Co. Ltd. | HIGH-THROUGHPUT SEQUENCE-BASED PROCEDURE FOR GENERATION OF CAMELID ANTIBODIES TO COVER WIDE EPITOPES WITH HIGH RESOLUTION |
-
2020
- 2020-12-28 WO PCT/IB2020/001079 patent/WO2021130535A2/en not_active Ceased
- 2020-12-28 EP EP20873349.3A patent/EP4081545A2/en active Pending
- 2020-12-28 US US17/758,128 patent/US20230058519A1/en active Pending
- 2020-12-28 CN CN202080090804.9A patent/CN115103857B/zh active Active
- 2020-12-28 JP JP2022539336A patent/JP2023515747A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023515747A5 (enExample) | ||
| TWI809130B (zh) | 嵌合跨膜蛋白及其用途 | |
| JP2021534835A5 (enExample) | ||
| Felices et al. | Generation of BiKEs and TriKEs to improve NK cell-mediated targeting of tumor cells | |
| JP7812877B2 (ja) | キメラポリペプチド及びそれらの細胞膜における局在を変更する方法 | |
| JP2024023228A5 (enExample) | ||
| JP2022109975A5 (enExample) | ||
| US20240342283A1 (en) | ROR1 CAR or ROR1 / CD19 Dual CAR T Cells for the Treatment of Tumors | |
| JP2022541742A5 (enExample) | ||
| JP2019531328A5 (enExample) | ||
| US12570958B2 (en) | Single- and multi-chain chimeric antigen receptors | |
| JP2018526033A5 (enExample) | ||
| JP2021532742A5 (enExample) | ||
| RU2018122106A (ru) | Буферы для стабилизации лентивирусных препаратов | |
| JP2024511423A5 (enExample) | ||
| WO2020214928A1 (en) | Bioassay for t-cell co-stimulatory proteins containing fc domains | |
| CN119894930A (zh) | 一种双特异性抗体及其应用 | |
| JP2025503644A5 (enExample) | ||
| CN117586411A (zh) | 一种结合tnfr2和ccr8的双特异性抗体 | |
| HK40019125A (en) | Chimeric polypeptides and methods of altering their localisation in the cell membrane | |
| NZ791176A (en) | Chimeric antigen receptors targeting bcma and methods of use thereof |